Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ITM Solucin GmbH
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
City of Hope Medical Center
Institut Curie
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Y-mAbs Therapeutics
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eisai Inc.
Children's National Research Institute
City of Hope Medical Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Iowa
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)